Literature DB >> 8876177

Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II.

H Okamoto1, C T Sheline, J L Corden, K A Jones, B M Peterlin.   

Abstract

Human immunodeficiency virus (HIV)-encoded trans-activator (Tat) acts through the trans-activation response element RNA stem-loop to increase greatly the processivity of RNA polymerase II. Without Tat, transcription originating from the HIV promoter is attenuated. In this study, we demonstrate that transcriptional activation by Tat in vivo and in vitro requires the C-terminal domain (CTD) of RNA polymerase II. In contrast, the CTD is not required for basal transcription and for the formation of short, attenuated transcripts. Thus, trans-activation by Tat resembles enhancer-dependent activation of transcription. These results suggest that effects of Tat on the processivity of RNA polymerase II require proteins that are associated with the CTD and may result in the phosphorylation of the CTD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876177      PMCID: PMC38099          DOI: 10.1073/pnas.93.21.11575

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.

Authors:  H Kato; H Sumimoto; P Pognonec; C H Chen; C A Rosen; R G Roeder
Journal:  Genes Dev       Date:  1992-04       Impact factor: 11.361

2.  Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin.

Authors:  C T Sheline; L H Milocco; K A Jones
Journal:  Genes Dev       Date:  1991-12       Impact factor: 11.361

3.  HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.

Authors:  M F Laspia; A P Rice; M B Mathews
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

4.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.

Authors:  S Y Kao; A F Calman; P A Luciw; B M Peterlin
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

5.  Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat.

Authors:  M J Selby; E S Bain; P A Luciw; B M Peterlin
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

6.  Inhibition of in vivo and in vitro transcription by monoclonal antibodies prepared against wheat germ RNA polymerase II that react with the heptapeptide repeat of eukaryotic RNA polymerase II.

Authors:  N E Thompson; T H Steinberg; D B Aronson; R R Burgess
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

7.  The HIP1 initiator element plays a role in determining the in vitro requirement of the dihydrofolate reductase gene promoter for the C-terminal domain of RNA polymerase II.

Authors:  A B Buermeyer; N E Thompson; L A Strasheim; R R Burgess; P J Farnham
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

8.  Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators.

Authors:  R Carroll; B M Peterlin; D Derse
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex.

Authors:  N J Keen; M J Gait; J Karn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

10.  Purification using polyethylenimine precipitation and low molecular weight subunit analyses of calf thymus and wheat germ DNA-dependent RNA polymerase II.

Authors:  H G Hodo; S P Blatti
Journal:  Biochemistry       Date:  1977-05-31       Impact factor: 3.162

View more
  39 in total

1.  hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation.

Authors:  M K Kim; V M Nikodem
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner.

Authors:  C Suñé; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Authors:  Ran Taube; Xin Lin; Dan Irwin; Koh Fujinaga; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3'-end cleavage.

Authors:  Emanuel Rosonina; Benjamin J Blencowe
Journal:  RNA       Date:  2004-04       Impact factor: 4.942

Review 5.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

6.  Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells.

Authors:  Dorota Kaniowska; Rafal Kaminski; Shohreh Amini; Sujatha Radhakrishnan; Jay Rappaport; Edward Johnson; Kamel Khalili; Luis Del Valle; Armine Darbinyan
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

7.  FF domains of CA150 bind transcription and splicing factors through multiple weak interactions.

Authors:  Matthew J Smith; Sarang Kulkarni; Tony Pawson
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.

Authors:  Q Zhou; D Chen; E Pierstorff; K Luo
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

9.  Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T.

Authors:  K Fujinaga; R Taube; J Wimmer; T P Cujec; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication.

Authors:  S F Ding; J Noronha; S Joshi
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.